Drug makers urged to elevate patient input in R&D
This article was originally published in SRA
Executive Summary
The pharmaceutical industry's incorporation of patients' perspectives in drug development has been limited, to date, with manufacturers usually only seeking the advice of patients in response to specific information requests.